American company Advanced Medical Solutions International (AMSI) announced development of non-invasive, touchless, immediate, and portable detector of the virus SARS-CoV-2 which causes the disease COVID-19, demonstrating >99% specificity and sensitivity within 0-2 meters (6.5 feet) on surfaces, through glass or transparent material, and inside the human body.
· Immediate detection of 2 internal and external components of SARS-CoV-2 (such as RNA or spike protein) in a specific and sensitive manner
· Immediate detection of SARS-CoV-2 in
any human sample, including nasal swabs, oral swabs, sputum, saliva,
bronchoalveolar lavage (lung aspirate)
· Immediate detection of SARS-CoV-2
inside human body (identification of people infected with SARS-CoV-2
(“carriers”)) in a non-invasive manner
· Immediate detection of SARS-CoV-2 in air coughed or sneezed or blown out of mouth or nose of infected people into a transparent container (identification of people infected with SARS-CoV-2 AND who are infectious (transmitters of infection))
· Immediate detection of SARs-CoV-2 in
different body organs (throat, lung, sinus)
· Immediate detection of SARS-CoV-2 on
the outside of human body (skin and clothes)
· Immediate detection of SARS-CoV-2 on
contaminated objects (such as door handles, mobile phones, high-touch surfaces,
packages, etc.)
· Verification of RT-PCR results of
COVID19 (SARS-CoV-2) infection to eliminate false readings
AMSI is
working with Biologics Consulting Group, Inc. to handle the FDA Emergency Use Authorization
(EUA) submission for The COVID Hunter.
Комментариев нет:
Отправить комментарий